Ibio Inc IBIO

Healthcare Biotechnology

iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu technology is an AI-based tool designed to predict a library of antibodies with fully human Complementarity-Determining Region (CDR) variants based on an input antibody. Its pre-clinical pipeline of immuno-oncology targets the treatment of solid tumors, glioblastoma, head, and neck cancers. Its pipeline includes IBIO-101, TROP-2 x CD3, MUC16, EGFRvIII, CCR8, and Target 5. IBIO-101 is an anti-CD25 monoclonal antibody (mAb) that has demonstrated in preclinical models of disease the ability to bind and deplete immunosuppressive regulatory T (Treg) cells to inhibit the growth of solid tumors.

NYSEAM:IBIO - Post by User

Ibio Inc

<< Previous

Bullboard Posts

Next >>

Post by FelixFunon Aug 09, 2020 5:47am

280 Views

Post# 31384047

$iBio - What goes up behind the scenes ... ???

$IBIO Trying to get to the bottom of this 25% discussion people have been talking about, we dug into the SEC Filings and tried to create a timeline. Nagging question: Why did Dart's lawyer (Sullivan) and iBio's lawyer (Abramowitz) both use the June's date float of 119 million given that there was 23 million shares issued since then? What we came up with is that Dart had an opportunity turn a profit, dilute himself through conversion, and gain shares/voting power while buying millions of shares cheaply and staying under the radar of the SEC and/or helping iBio get BARDA funding (which would be very beneficial to him). Or forget the 25% issue all together and keep it simple. He had a chance to recoup his investment costs/turn a profit, and gain voting power, and buy more shares. Keep in mind: He couldn't buy until the end of June (standstill). Some Things to Research in regards to the 25% Threshold. § 120.37 . §120.1(c)(1)

Source: https://stocktwits.com/iBio_Cultist

Float, Dart, Shares
BARDA V entures